We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$15.5M
Cap. Flow
-$2.37M
Cap. Flow %
-0.63%
Top 10 Hldgs %
58.23%
Holding
131
New
17
Increased
44
Reduced
24
Closed
14

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$9.91M
2
SE icon
Sea Limited
SE
+$4.23M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.68M
4
CPNG icon
Coupang
CPNG
+$3.22M
5
ROIV icon
Roivant Sciences
ROIV
+$3.13M

Top Sells

Rank Stock Value
1
ROKU icon
Roku
ROKU
+$10.8M
2
SPOT icon
Spotify
SPOT
+$10.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.21M
4
MRK icon
Merck
MRK
+$5.24M
5
HTZWW
Hertz Global Holdings Warrants
HTZWW
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 28.06%
2 Technology 25.23%
3 Consumer Discretionary 19.31%
4 Communication Services 15.2%
5 Miscellaneous 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPOT icon
1
Spotify
SPOT
$113B
$44.9M 11.98%
170,000
-43,000
-20% -$10.1M
SHOP icon
2
Shopify
SHOP
$197B
$32M 8.55%
415,000
– –
TSLA icon
3
Tesla
TSLA
$1.38T
$29.7M 7.93%
169,000
+50,700
+43% +$9.91M
AMZN icon
4
Amazon
AMZN
$2.87T
$25.4M 6.79%
141,000
– –
OXY.WS icon
5
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$21.4M 5.71%
496,207
– –
SNOW icon
6
Snowflake
SNOW
$114B
$20.8M 5.57%
129,000
– –
PRQR icon
7
ProQR Therapeutics
PRQR
$323M
$12.2M 3.27%
5,344,446
– –
SE icon
8
Sea Limited
SE
$73.1B
$11.3M 3.01%
210,000
+92,000
+78% +$4.23M
PLTR icon
9
Palantir
PLTR
$448B
$10.2M 2.73%
445,000
+20,000
+5% +$426K
RARE icon
10
Ultragenyx Pharmaceutical
RARE
$2.52B
$10M 2.68%
215,102
+48,596
+29% +$2.29M
IONS icon
11
Ionis Pharmaceuticals
IONS
$10.1B
$9.84M 2.63%
226,993
+9,500
+4% +$453K
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.24T
$9.06M 2.42%
60,000
-10,000
-14% -$1.43M
DDOG icon
13
Datadog
DDOG
$85.1B
$8.16M 2.18%
65,993
– –
ARWR icon
14
Arrowhead Research
ARWR
$12B
$7.83M 2.09%
273,936
– –
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.53M 2.01%
108,883
+14,900
+16% +$1.02M
NET icon
16
Cloudflare
NET
$107B
$7.26M 1.94%
75,000
– –
AXSM icon
17
Axsome Therapeutics
AXSM
$10.4B
$6.55M 1.75%
82,032
+10,000
+14% +$839K
RCKT icon
18
Rocket Pharmaceuticals
RCKT
$424M
$6.33M 1.69%
235,050
+2,000
+0.9% +$56.8K
MRK icon
19
Merck
MRK
$366B
$6M 1.6%
45,497
-42,481
-48% -$5.24M
ROIV icon
20
Roivant Sciences
ROIV
$25.1B
$5.98M 1.6%
567,795
+290,000
+104% +$3.13M
NVDA icon
21
NVIDIA
NVDA
$5.25T
$5.42M 1.45%
60,000
-12,000
-17% -$870K
FUSN
22
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$5.35M 1.43%
251,158
+109,408
+77% +$1.31M
CRWD icon
23
CrowdStrike
CRWD
$224B
$4.81M 1.28%
60,000
-4,000
-6% -$306K
MSFT icon
24
Microsoft
MSFT
$3.81T
$4.38M 1.17%
10,400
-5,600
-35% -$2.27M
MRNA icon
25
Moderna
MRNA
$55.1B
$4.25M 1.13%
39,861
-4,000
-9% -$403K
1
2 3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, Privium Fund Management held 131 positions worth $374M, up 4.3% from $359M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Privium Fund Management's Q1 2024 filing shows 17 new, 44 increased, 24 reduced and 14 closed positions. Its largest new stake was Acadia Pharmaceuticals: 148,400 shares worth $2.74M. The largest sale was Roku, an estimated $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Privium Fund Management's largest Q1 2024 buy was Acadia Pharmaceuticals: 148,400 shares worth $2.74M.
  • Privium Fund Management added most to Tesla in Q1 2024, an estimated $9.91M increase.
  • Privium Fund Management's biggest Q1 2024 reduction was Spotify, cutting an estimated $10.1M.
  • Privium Fund Management fully exited Roku in Q1 2024, selling an estimated $10.8M.
  • Privium Fund Management's ten largest holdings make up 58% of its $374M portfolio in Q1 2024.
  • Privium Fund Management opened 17 new positions and closed 14 in Q1 2024.
  • Privium Fund Management's portfolio value rose 4.3% quarter-over-quarter to $374M.

Based on Privium Fund Management's 13F filing for Q1 2024, filed 30 Apr 2024.